APA (7th ed.) Citation

Pollom, E. L., Fujimoto, D., Wynne, J., Seiger, K., Modlin, L. A., Jacobs, L. R., . . . Choi, C. Y. (2017). Phase 1/2 Trial of 5-Fraction Stereotactic Radiosurgery With 5-mm Margins With Concurrent and Adjuvant Temozolomide in Newly Diagnosed Supratentorial Glioblastoma: Health-Related Quality of Life Results. International Journal of Radiation Oncology, Biology, Physics, 98(1), 123. https://doi.org/10.1016/j.ijrobp.2017.01.242

Chicago Style (17th ed.) Citation

Pollom, Erqi L., et al. "Phase 1/2 Trial of 5-Fraction Stereotactic Radiosurgery With 5-mm Margins With Concurrent and Adjuvant Temozolomide in Newly Diagnosed Supratentorial Glioblastoma: Health-Related Quality of Life Results." International Journal of Radiation Oncology, Biology, Physics 98, no. 1 (2017): 123. https://doi.org/10.1016/j.ijrobp.2017.01.242.

MLA (9th ed.) Citation

Pollom, Erqi L., et al. "Phase 1/2 Trial of 5-Fraction Stereotactic Radiosurgery With 5-mm Margins With Concurrent and Adjuvant Temozolomide in Newly Diagnosed Supratentorial Glioblastoma: Health-Related Quality of Life Results." International Journal of Radiation Oncology, Biology, Physics, vol. 98, no. 1, 2017, p. 123, https://doi.org/10.1016/j.ijrobp.2017.01.242.